Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

NCT01294358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

NIH

Sponsor class

Conditions

Histologically or Cytologically Confirmed Pancreatic Ca
Unresectable or Borderline Resectable Pancreatic Ca

Interventions

DRUG: Gemcitabine

Sponsor

National Cancer Institute (NCI)